Camtek (NASDAQ:CAMT) Stock Price Expected to Rise, Stifel Nicolaus Analyst Says

Camtek (NASDAQ:CAMT - Get Free Report) had its price target raised by Stifel Nicolaus from $84.00 to $98.00 in a note issued to investors on Monday,Benzinga reports. The brokerage currently has a "buy" rating on the semiconductor company's stock. Stifel Nicolaus' price target would indicate a potential upside of 9.55% from the company's previous close.

CAMT has been the subject of a number of other research reports. Evercore ISI lowered their target price on Camtek from $100.00 to $82.00 and set an "outperform" rating for the company in a research note on Wednesday, May 14th. Needham & Company LLC dropped their price target on Camtek from $110.00 to $80.00 and set a "buy" rating on the stock in a research report on Wednesday, May 14th. Cantor Fitzgerald set a $80.00 price objective on Camtek and gave the company a "neutral" rating in a research report on Tuesday, June 24th. Bank of America lowered their price objective on Camtek from $105.00 to $80.00 and set a "buy" rating for the company in a research note on Wednesday, April 16th. Finally, Wall Street Zen raised Camtek from a "sell" rating to a "hold" rating in a research note on Wednesday, May 21st. Two research analysts have rated the stock with a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $89.00.

Camtek Price Performance

Camtek stock traded down $0.68 during midday trading on Monday, hitting $89.46. 214,882 shares of the company's stock were exchanged, compared to its average volume of 552,700. The stock has a 50-day moving average price of $74.09 and a two-hundred day moving average price of $75.13. Camtek has a 52-week low of $47.41 and a 52-week high of $133.74. The company has a market cap of $4.08 billion, a P/E ratio of 34.28, a PEG ratio of 2.46 and a beta of 1.34. The company has a debt-to-equity ratio of 0.34, a quick ratio of 4.27 and a current ratio of 5.28.

Camtek (NASDAQ:CAMT - Get Free Report) last posted its earnings results on Tuesday, May 13th. The semiconductor company reported $0.79 earnings per share for the quarter, topping analysts' consensus estimates of $0.77 by $0.02. The company had revenue of $118.64 million during the quarter, compared to analyst estimates of $119.00 million. Camtek had a net margin of 28.40% and a return on equity of 24.57%. Camtek's revenue for the quarter was up 22.3% on a year-over-year basis. During the same period in the prior year, the business posted $0.63 earnings per share. On average, equities research analysts forecast that Camtek will post 2.93 earnings per share for the current year.

Hedge Funds Weigh In On Camtek

A number of institutional investors and hedge funds have recently modified their holdings of CAMT. Clal Insurance Enterprises Holdings Ltd boosted its position in Camtek by 27.8% in the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 2,134,671 shares of the semiconductor company's stock worth $123,622,000 after purchasing an additional 464,671 shares during the last quarter. Menora Mivtachim Holdings LTD. lifted its stake in shares of Camtek by 81.8% in the 4th quarter. Menora Mivtachim Holdings LTD. now owns 1,566,433 shares of the semiconductor company's stock worth $126,521,000 after purchasing an additional 705,000 shares during the period. Migdal Insurance & Financial Holdings Ltd. lifted its stake in shares of Camtek by 27.6% in the 1st quarter. Migdal Insurance & Financial Holdings Ltd. now owns 1,448,441 shares of the semiconductor company's stock worth $84,922,000 after purchasing an additional 312,988 shares during the period. Wasatch Advisors LP grew its position in Camtek by 311.8% during the fourth quarter. Wasatch Advisors LP now owns 1,192,784 shares of the semiconductor company's stock valued at $96,341,000 after buying an additional 903,126 shares during the period. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its position in Camtek by 110.5% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,015,307 shares of the semiconductor company's stock valued at $59,527,000 after buying an additional 532,944 shares during the period. 41.93% of the stock is currently owned by hedge funds and other institutional investors.

Camtek Company Profile

Camtek Ltd., together with its subsidiaries, develops, manufactures, and sells inspection and metrology equipment for semiconductor industry. The company provides Eagle-i, a system that delivers 2D inspection and metrology capabilities; Eagle-AP, which addresses the advanced packaging market using software and hardware technologies that deliver superior 2D and 3D inspection and metrology capabilities on the same platform; and Golden Eagle, a panel inspection and metrology system to address the challenges fanout wafer level packaging applications.